Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced a distribution agreement with the Indian distributor Hansraj Nayyar Medical. Sales will commence in the fall and a registration process will start in parallel. Hansraj Nayyar has committed to a first framework order of 25,000 euros. The Indian market potential for sedation in intensive care is estimated to be around two million ventilation days annually.
“Hansraj Nayyar is a pioneer in Indian intensive care and it is very gratifying that they will now launch our therapy.” said Christer Ahlberg, CEO of Sedana Medical.